Skip to content

6-KAccepted Sep 18, 8:16 AM ET

PHAXIAM Therapeutics S.A. 6-K

PHAXIAM Therapeutics S.A.

Accepted (ET)

8:16 AM

Sep 18, 2023

Filed

Sep 18, 2023

Documents

3

Size

39.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.